Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells

Prostaglandins

Volumn 51, Issue 1, 1996, Pages 1-17

  Reich, Reuven ^a,b   Martin, George R ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

arachidonic acid; collagenase; cyclooxygenase; invasion; lipoxygenase; metastasis

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; ARACHIDONIC ACID; COLLAGENASE; LIPOXYGENASE; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE;

ARACHIDONIC ACID METABOLISM; ARTICLE; BASEMENT MEMBRANE; CANCER CELL; CANCER INVASION; CELL MOTILITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; METASTASIS; PROTEIN DEGRADATION; REGULATORY MECHANISM;

EID: 0041590826     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/0090-6980(95)00154-9     Document Type: Article

References (67)

1. Sugarbaker, E.V., Weingard, D.N., and Roseman, J.M. (1982) Observations on cancer metastases, Cancer Invasion and Metastases. Edited by L.A. Liota, I.R. Hart. Boston, Martinus Nighoff, pp. 427-465.
2. Fidler, I.J., Critical factors in the biology of human cancer metastasis. Cancer Res. 50: 6130-6138 1990.
3. Fidler, I.J., Gersten, D.M., and Hart, I.R. The biology of cancer invasion and metastasis. Adv. Cancer Res. 28: 149-250 1978.
4. Poste G. and Fidler, J. The pathogenesis of cancer metastasis. Nature 283: 139-146 1980.
5. Fidler, I.J., Therapy of cancer metastasis by systemic activation of macrophages. Advances in Pharmacol. 30: 271-326 1994.
6. Strauli, P. A concept of invasion. In: P. Strauli, A.J. Barrett, A. Baici (eds.) Proteinases and tumor invasion. EORTC Monograph series. Vol. 6, pp. 1-15, New York, Raven Press, 1980.
7. Weiss, L., and Ward, P.M. Cell detachment and metastasis. Cancer Metastasis Rev. 2: 111-123 1983.
8. Mullins, D.E., and Rohrlich, S.T. The role of proteinases in cellular invasiveness. Biochim. Biophys. Acta 695: 177-214 1983.
9. Liotta, L.A., Mandler, A., Murano, G., Katz, D.A., Gordon, R.K., Chiang, P.K. and Schiffmann, E. Tumor cell autocrine motility factor. Proc. Natl. Acad. Sci. USA 83: 3302-3306 1986.
10. Laurie, G.W., Leblond, C.P., Martin, G.R. Light microscopic immunolocalization of type IV collagen, laminin, heparan sulfate proteoglycan and fibronectin in the basement membranes of a variety of rat organs. Am. J. Anatomy 167: 71-82 1983.
11. Martin, G.R., and Timpl R, (1987) Laminin and other basement membran ecomponenets. Ann Rev. Cell Biol. 3: 57-85 1987.
12. Poole, A.R., Tutman, K.J., Recklies, A.D., and Stoker, T.A.M. Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature 273: 545-547 1978.
13. Recklies, A.D., Mort, J.S., and Poole, A.R. (1982) Secretion of a thiol proteinase from mouse mammary carcinomas and its characterization. Cancer Resa 42: 1026-1032 1982.
14. Dresden, M.H., Heilman, S.A. and Schmidt, J.D. Collagenolytic enzymes in human neoplasms. Cancer Res. 22: 993-996, 1972.
15. Hashimoto, K., Yamanishi, Y., Maeyens, E., Dabbous, M.K. and Kanzaki, T. Collagenolytic activityies of squamous cell carcinom a of the skin. Cancer Res. 33: 2790-2801 1973.
16. Woolley, D.E. Collagenolytic mechanisms of tumor cell invasion. Cancer Met. Rev. 3: 361-372 1984.
17. Mignatti P., Robbins E., Rifkin D.B. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 67: 687-698 1986.
18. Liotta, L.A., Abe, S., Gehron-Robey, P. and Martin, G.R. Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc. Natl. Acad. Sci. USA 76: 2268-2272 1979.
19. Pauli B.U., Arsemis, C., Hohberger, L.H., and Schwartz, D.E. Connective tissue degradation by invasive rat bladder carcinomas: Action of nonspecific proteinases on collagenous matrices. Cancer Res. 46: 2005-2012 1986.
20. Zucker, S., Beck, G., DiStefano, J.F., and Lysik, R.M. Role for different cell proteinases in cancer invasion and cytolysis. Br. J. Cancer 52: 223-232 1985.
21. Reich, R., Thompson, E., Iwamoto, Y., Martin, G.R., Deason, J.R. Fuller, G.G., Miskin R. Inhibition plasminogen activator, serine proteinases and collagenase IV prevents the invasion of basement membranes by metastatic cells. Cancer Res. 48: 3307-3312 1988.
22. Wilhelm, S.M., Collier, I.E., Kronberger, A., Eisen, A.Z., Marmer, B.L., Grant, G.A., Bauer, EA., and Goldberg, G.I. Human skin fibroblast stromelysin: structure, glycosylation, subsrate specificity, and differential expression in normal and tumorigenic cells. Proc. Natl. Acad. Sci. USA 84: 6725-6729 1987.
23. Pipoly, D.J., and Crouch, E.C. Degradation of native type IV procollagen by human neutrophil elastase. Implications for leukocyte-mediated degradation of basement membranes. Biochemistry 26: 5748-5754 1987.
24. Zucker, S., Weiman, J.M., Lysik, R.M., Wilkie, D., Ramamurthy, N.S., Colub, L.M. and Lane, B Enrichment of collagen and gelatin degrading activities in the plasma membranes of human cancer cells. Cancer Res. 47: 1608-1614 1987.
25. Turpeenniemi-Hujanen, T., Thorgeirsson, U.P., Rao, C.N., Liotta, L.A. Laminin increases the release of type IV collagenase from malignant cells. J. Biol. Chem. 4: 1883-1889 1986.
26. Liotta, L.A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C.M., and Shafie, S. Metatatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67-68 1980.
27. Salo, T., Liotta, L.A., Kewski-OJA, J., Turpeenniemi-Hujanen, T., and Tryggvason, K. (1982) Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells - role in metastasis. Int. J. Cancer 30: 669-673 1982.
28. Terranova, V.P., Hujanen, E.S., and Martin, G.R. Basement membrane and the invasive activity of metastatic tumor cells. JNCI, Vol. 77, 311-316 1986.
29. Reich, R., Blumenthal, M., and Liscovitch M., Role of PLD in laminin -induced production of gelatinase A (MMP-2) in metastatic Cells . Exp. and Clin. Metast. 13, 134-140 1995.
30. Hujanen, E.S., and Terranova, V.P. Migration of tumor cells to organ-derived chemoattractants. Cancer Res. 45: 3517-3521 1985.
31. Hamberg M., Svensson T., Wakabayashi T., Samuelsson B. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc. Natl. Acad. Sci. USA 71: 345-349 1974.
32. Borgeat P., Samuelsson B. Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a neutral dihydroxyeicosatetraenoic acid. J. Biol. Chem. 254: 2643-2648 1979.
33. Hammartrom S. Leukotrienes. Annu. Rev. Biochem. 52: 355-77 1983.
34. Dayer, J.M., Krane, S.M., Russell, R.G. and Robinson, D.R. Production of collagenase and prostaglandin by isolated adherent rheumatoid synovial cells. Proc. Natl. Acad. Sci. USA 73: 945-949 1976.
35. Dayer, J.M., Roelke, M.S., and Krane, S.M. Effects of prostalgandin E2, indomethacin, trifluoroperaziane and drugs affecting the cytoskeleton on collagenase production by cultured adherent rheumatoid synovial cells. Biocehm. Pharmacol. 33: 2893-2899 1984.
36. Wahl, L.M., C.E. Olsen, A.L. Sandberg, S.E. Mergenhagen, Prostaglandin regulation of macrophage colagenase production. Proc. Natl. Acad. Scu. USA 74: 4955-4958 1977.
37. Wahl S.M., Wahl L.M. Regulation of macrophage collagenase, prostaglandin and FAF production by anti-inflammatory agents: different regulatory mechanisms for tissue injury and repair. Cellular Immunol. 92: 302-312 1985.
38. Wahl L.M., and L.L. Campel Regulation of human peripheralblood monocyte collagenase by prostaglandins and antiinflammatory drugs. Cellular Immunol. 105: 411-422 1984.
39. Reich R., Tsafriri A., Mechanic GL The involvement of collagenolysis in ovulation. Endocrinol. 116, 522-527 1985.
40. Reich, R., Daphna-Iken, D., Chun, S.Y., Popliker, M., Slager, R., AdelmannGrill, B.C. and Tsafriri A. Preovulatory changes in ovarian expression of collagenases and tissue metalloproteinase inhibitor mRNA: Role of eicosanoids. Endocrinology ,129: 1869-1875, 1991.
41. Rasheed, S., Nelson-Rees, W.A., Toth, E.M., Arnstein, P., and Gardner, M.B. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33, 1027-1033 1974.
42. Tamadge, J.E., and Fidler, I.J. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogenous murine tumors. JNCI 69: 975-980 1982.
43. Fidler, I.J. Selection of successive tumor lines for metastasis. Nature New Biology 242: 148-149 1973.
44. Albini, A., Graf, J., Kitten, G., Kleinman, H.K., Martin, G.R., Veillette, A. and Lippman, M. 17b estradiol regulates and v-ras transfection constitutively enhances MCF-7 breast cancer cells interaction with the basement membrane. Proc. Nat. Acad. Sci. USA 83: 8182-8186 1986.
45. Albini, A., Iwamoto, Y., Kleinman, H.K., Marti, G.R., Aaronson, S.A., Kozlowski, J.M., McEwan, R.N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47: 3239-3245 1987.
46. Kleinman H.k., McGarvey, M.L.,Hassell, J.R., Star, V.L., Cannon, F.B., Laurie, G.W., and Martin, G.R. Basement membrane complexes with biological activity. Biochemistry 25: 312-318 1986.
47. Menzel, J., and Borth, W. Influence of plasma fibronectin on collagen cleavage by collagenase . Coll Rel. Res. 3: 217-230 1983.
48. Ballin M., Gomez, DE., Sinha, CC, and Thorgeirsson UP., Ras oncogene mediated activationof 92 kDa metalloproteinase showing correlation with the malignant phenotype Biochem Biophys. Res. Commun. 154: 832-838 1988.
49. Jakschnik, B.A., Harper, T.and Murphy, R.C. The 5-lipoxygenase and leukotriene forming enzymes. Methods in Enzymology 86, 30-37, 1982.
50. Kramer, R.H., Bensch,K.K., and Wong, J. Invasion of reconstituted basement membrane matrix by metastatic tumor cells. Cancer Res. 46: 1980-1989 1986.
51. Newell KJ., Witty JP., Rodgers WH., and Matrisian LM., Expression and localization of matrix degrading metalloproteinases during colorectal tumorigenesis. Moec. Carcinogen. 10: 199-206 1994.
52. Powles, T.J., Bockman, R.S., Honn, K.V., and Ramwell, P. Prostaglandins and Cancer; First International Conference. New York: Alan R. Liss, Inc 1981 pp 67.
53. McCormick D.L., Moon R.C. Inhibition of mammary carcinogenesis by flurbiprofen a non-steroidal anti-inflammatory agent. Br. J. Cancer 48: 859-861 1983.
54. Bando H., Yanashita T., Srubura E., Effects of antiplatelet agents on pulmonary metastases. Gann 75: 284-291 1984.
55. Rubio C.A. Antitumoral activity of indomethacin on experimental esophageal tumors. JNCI 72: 705-707 1984.
56. Bennett A., Carroll M.A., Melhnish P.B., Stanford, I.F. Treatment of mouse carcinoma in vivo with a prostaglandin E2 analogue and indomethacin. Br. J. Cancer 52: 245-249 1985.
57. Bennett, A., mcDonald, A.M., Simpson, J.S., Stanford, I. Breast cancer, prostaglandin and bone metastases. Lancet 1: 1218-1220 1975.
58. Bergman, M.D., Funk, C., and Fukushima, M. Inhibition of human melanoma growth by prostglandin A, D, and J analogues. Cancer Res. 46: 2740-2744 1986.
59. Honn KV., Tang DG., and Crissman JD., Platelets and cancer metastasis: a casual relationship? Cancer and Met Rev. 11: 325-351 1992.
60. Honn KV., Tang DG., Grossi IM., Renaud C., Duniec ZM., Johnson CR., and Diglio CA., Enhanced endothelial cell retraction mediated by 12-HETE: A proposed mechanism for the role of platelets in tumor cell metastasis. Exper. Cell Res. 210: 1-9 1994.
61. Honn KV., Tang DG., Grossi IM., et al. Tumor cell derived 12-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction. Cancer Res. 54: 565-574 1994
62. Tang DG., Diglio CA., and Honn K.V., Activation of microvascular endothelium by eicosanoid 12 hydroxyeicosatetraenoic acidleads to enhanced tumor cell adhesion via up regulation of surface expression of avb3 integrin: A post transcriptional protein kinase C and cytoskleton dependent process. Cancer Res. 54: 1119-1129 1994.
63. Crissman, J.D., Hatfield, J.S., Menter, D.G., Sloane, B., Honn, K.V., Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res. 48:4065-72 1988.
64. Hanna, N. and Fidler, I.J. Role of natural killer cells in the destruction of circulating tumor emboli. JNCI 65: 801-809 1980.
65. Reich, R., Royce, L., Martin, G.R. Eicosapentaenoic acid reduces the invasive and metastatic activities of malignant tumor cells, biochem. Biophys. Res. Comm. 160: 559-564 1989.
66. Rose DP., Rayburn J., Halata MA., and Connolly JM., Effects of dietary fish oil on fatty acids and eicosanoids in metastasizing human breast cancer cells. Nutrition and Cancer 22: 131-141 1994.
67. Honn KV., Tang DG., Gao X., Butovich IA., Liu B., Timar J., Hagmann W. 12-Lipoxygenase and 12(S)-HETE: role in cancer metastasis. Cancer and Met Rev. 13, 365-396 1994.